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ABSTRACT 
DOES LACTOBACILLUS REUTERI PROBIOTIC TREATMENT IMPROVE 
SLEEP QUALITY IN RHESUS MACAQUES (MACACA MULATTA) 
DISPLAYING THE SELF INJURIOUS PHENOTYPE?  
 
FEBRUARY 2019 
PETER N. MCGINN, B.S., UNIVERSITY OF MASSACHUSETTS 
M.S., UNIVERSITY OF MASSACHUSETTS 
Directed by: Professor Melinda A. Novak 
 
Self-injurious behavior (SIB) is a complex phenotype that occurs with an 
increasing prevalence of about 7-34% in humans and 10-12% in non-human primates 
(NHPs). This study evaluated the efficacy of probiotic Lactobacillus reuteri as a 
treatment for self-injurious behavior (SIB) and sleep disruption in rhesus macaques. The 
treatment was proposed to alleviate mild self-biting, sleep disruption, and reduce 
chronically elevated hypothalamic-pituitary-adrenocortical (HPA) axis activity, all 
hallmark features of monkeys with this condition. The probiotic preparation included two 
strains of L. reuteri (L. reuteri ATCC PTA 6475 & L. reuteri DSM 17938) containing on 
average 200 million colony forming units per chewable tablet. The study was conducted 
on 14 rhesus macaque monkeys (9 males) housed at the University of Massachusetts 
Amherst. To our knowledge this is the first time that a Lactobacillus strain has been used 
as a treatment for SIB in rhesus macaques. This study utilizes motion-activated infrared 
camera technology, modified enzyme-immunosorbent-assays (EIAs) techniques to 
measure hair cortisol concentrations, and daily behavioral observations to provide an 
overall assessment of the behavioral, physiological, and sleep associated implications of 
probiotic treatment on SIB and control non-human primates (NHPs). Administration of L 
 viii 
reuteri modestly decreased biting behavior in monkeys with SIB (F(2,12) = 5.64, p= 0.02) 
and showed overall decrease in nighttime activity across all subjects but did not 
normalize SIB to nonSIB values. Hair cortisol values are pending. These findings and the 
findings of previous work further strengthen the argument for probiotics as an efficacious 
treatment for SIB behavior. 
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 1 
CHAPTER 1  
INTRODUCTION 
This study is a continuation of previous work evaluating the efficacy of probiotics 
to treat self-injurious behavior (SIB) and sleep disruption in rhesus macaques. It explores 
the efficacy of Lactobacillus reuteri, in alleviating the dominant SIB behaviors such as 
mild self-biting and hair-pulling as well as restoring balance to a chronically elevated 
hypothalamic-pituitary-adrenocortical (HPA) axis activity. The probiotic preparation 
includes two strains of L. reuteri (L. reuteri ATCC PTA 6475 & L. reuteri DSM 17938) 
containing on average 200 million colony forming units per chewable tablet. These 
strains have been shown in human and rodent models to influence the neurological, 
immune, and gastro-intestinal systems. To our knowledge this is the first time that a 
Lactobacillus strain has been used as a treatment for SIB in rhesus macaques and may 
begin to fill in the many gaps left by the focus on rodent models. 
 This study utilizes motion-activated infrared camera technology, modified 
enzyme-immunosorbent-assays (EIAs) techniques to measure hair cortisol 
concentrations, and daily behavioral observations to provide an overall assessment of the 
behavioral, physiological, and sleep associated implications of probiotic treatment on SIB 
and control non-human primates (NHPs).  
 
1.1 Self-injurious Behavior (SIB) 
SIB is idiopathic, meaning symptoms are not detected until onset, thus 
establishing cause and effect relationships is challenging (Novak 2003). However, one 
can retrospectively identify relevant factors in the pathology. The current working model 
of SIB in NHPs, as identified by our lab, is a coupling of early life stress in the form of 
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nursery rearing (Lutz et al. 2003, 2007) in concert with allelic variation in certain 
candidate genes related to serotonin expression and opioid receptor activity (Novak 2003, 
Chen et al. 2010). The presence of genetic factors and early life trauma does not 
guarantee SIB pathology, but retrospectively is typical of the majority of subjects 
displaying SIB behavior (Chen et al. 2010). 
Interestingly, SIB can vary in intensity. It can present in mild forms: such as hair 
pulling or infrequent and mild self-biting. However, a more severe form includes both a 
higher incidence of SIB along with bites leading to wounds requiring veterinary care 
(Novak 2003). Mild cases are typically monitored but not treated. Deep wounding 
behaviors are more variable and can increase in frequency due to increased exposure to 
chronic stress such as cage relocation (Davenport et al. 2008).  
Despite the variation described above, our lab has identified a number of key 
correlates of SIB such as chronically dysregulated hypothalamic-pituitary-adrenocortical 
axis activity (Davenport et al. 2006), increased anxiety (Tiefenbacher et al. 2005, Major 
et al. 2009), and increased sleep disruption that are documented in both mild and severe 
manifestations (Davenport et al. 2008, Stanwicks et al. 2017). It is important to also 
acknowledge that the prevalence of SIB in captive NHPs is not necessarily a result of 
captivity as the condition has also been documented in free-ranging Japanese macaques 
(Grewal 1981).  
SIB is an increasingly significant problem in the human population and shares 
some commonalities with this pathology in monkeys. In humans, SIB is referred to as 
non-suicidal self-injurious behavior (NSSI) which is under consideration as a discrete 
disorder in DSM-5. NSSI can take several forms including but not limited to: burning, 
cutting, or even repeated picking at skin or hair (Simeon & Favazza 2001, Butler & 
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Malone 2013). NSSI can be a symptom of both genetic disorders such as Cornelia de 
Lange syndrome (Oliver et al. 2009) and psychiatric disorders like borderline personality 
disorder (Andover et al. 2011) but may also be triggered by early-life trauma (i.e. sexual 
abuse) (Briere & Gil 1998). It is suggested that NSSI may in fact fall into two subtypes; a 
reactive form in response to stressors and a compulsive form without a discernable 
stimulus (Simeon & Favazza 2001). Similar to rhesus macaques, humans with NSSI have 
sleep disruption (Brylewski & Wiggs 1999, Symons et al. 2000) and increased anxiety 
(Klonsky et al. 2003, Liu et al. 2017). 
Rodent research aligns with the correlates and predisposing factors of SIB found 
in human and macaque literature. The caveat being that rodent models of SIB are almost 
entirely chemically or surgically induced. Behaviors can range from mild self-biting and 
deep wounding (Guo et al. 2018, Kasim & Jinnah 2002) to excessive and repetitive 
grooming behaviors termed “barbering” (Greer & Capecchi 2002). Rodent SIB can be 
induced in a variety of ways including but not limited to environmental manipulation or 
through physiological stressors such as prolonged restraint (Guo et al. 2018), genetic 
mutations such as alterations or deletions in the Hoxb8, Shank3, and Sapap3 genes (Greer 
& Capecchi 2002, Peca et al 2011, Welch et al. 2007), and through intracerebral 
injections of pharmacological agents like muscimol (Baumeister & Frye 1984).  
Despite this artificial nature of induced rodent SIB, there remains important and 
key overlaps. As previously noted, rodent SIB behavior can be exaggerated with stressors 
and changing environmental demands such as isolation (Kasim & Jinnah 2002). 
Similarly, increased self-injury is thought to be paired with increased corticosterone 
levels implicating a role of the HPA axis in rodent SIB behavior (Guo et al. 2018). 
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Finally the role of genetic predisposing factors as previously mentioned, suggest that 
rodent SIB is a matter of not only nurture but also nature. 
To our knowledge there is lacking evidence for spontaneously occurring rodent 
SIB that closely mimics either human NSSI or macaque SIB. The similar but different 
nature of induced rodent SIB reinforces the need for rhesus macaques as a bi-translational 
model bridging the gap between rodent and human SIB research. 
 
1.2 Sleep Disruption  
 One of the features of SIB in monkeys is some form of sleep disruption 
(Davenport et al. 2008). The role of sleep in rhesus macaques with SIB has been well 
documented in our lab over three separate studies noting a robust SIB effect in the form 
of delayed sleep onset and increased nighttime activity (Davenport et al. 2008, Stanwicks 
et al. 2017, and Guresh unpublished data 2017). The three studies looked at two separate 
groups of rhesus macaques with varying intensity of SIB (i.e. wounding or mild biting) 
and measured nighttime activity during different years and at different times of the year. 
Regardless of these experimental manipulations the SIB effect has held firm. One 
primary aim of this study is to determine whether improvement in sleep quality will result 
in decreased SIB pathology. 
Nighttime activity has proven difficult to study in macaque species due to their 
curious nature and dexterity. Sleep activity recording technologies requiring direct 
contact with the subject must be strongly attached and carefully protected. Most sleep 
studies require macaque restraint or surgical implantation (Balzamo et al. 1998, Darbin et 
al. 2009). While these techniques are appropriate for traditional sleep studies, the 
restraints and external equipment may increase SIB behavior potentially confounding 
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results. Some studies have used less invasive techniques utilizing collars and actigraphy 
technology to measure movement (Barrett et al. 2009, Golub & Hogrefe 2016). While the 
devices can be securely and safely attached, they record all movements and do not give 
indication of type, eliciting stimulus, or context and often need to be paired with other 
measures. 
The study of macaque sleep disruption has improved in recent years. The initial 
Davenport study utilized a 1-minute point sampling method to scan nighttime activity 
taken once during and after cage relocation. Each 1-minute segment was scored on a 
scale of 0-3, with “0” indicating no nighttime activity (Davenport et al. 2008). Self-biters 
responded to the major life stress of relocation with exacerbated self-biting and increased 
nighttime activity (Davenport 2008). The scoring system proved to be tedious and 
subjective. The methodology was improved in a study utilizing infrared motion activated 
cameras, infrared light, and surveillance software set to record videos throughout the 
night any time the monkey moved (Stanwicks et al. 2017). The new technology allowed 
for subjects to be studied each week and eliminated the need for point sampling as the 
software only recorded upon detected movement. The SIB subjects once again showed 
increased sleep disruption and delayed sleep onset (Stanwicks et al. 2017). With the 
improved recording methodology, a secondary and smaller relocation study was 
conducted in response to an administratively mandated room change. The unpublished 
data reinforced the previous work, again demonstrating increased sleep disruption and 
delayed sleep onset in SIB monkeys, but did not show any effect of the relocation 
(Guresh Unpublished 2017). This current study will use a slightly more refined 
technology in which the cameras have built in infrared lights to observe sleep effects of 
Lactobacillus reuteri in both control and SIB subjects. 
 6 
Similar to our non-human primate models, NSSI in humans is correlated with 
sleep disruption (Symons et al. 2000). A benefit to human sleep studies is that they are 
often paired with subjective survey tools and indices that can provide valuable insight 
into perceived quality of sleep, daily anxiety scores, depression, and overall stress (Liu et 
al. 2017, Hysing et al. 2015). These in-depth questionnaires can be coupled with 
physiological indicators such as salivary melatonin concentrations, cortisol in blood 
plasma, and nighttime sleep measures (i.e. EEG, EMG, EOG).  
 Non-suicidal self-injurious behavior (NSSI) has been increasingly studied in 
humans revealing important connections between sleep and this disorder. Poor sleep and 
nightmares are associated with non-suicidal self-injury in adolescents (Liu X et al. 2017). 
Additional research is now beginning to suggest that HPA axis activity and sleep may 
have a bi-directional relationship. In cases of insomnia, increased HPA axis activity may 
be a causative factor preventing sleep and increasing instances of wakefulness (Buckley 
& Schatazberg, 2005 & Backhaus et al. 2003). In contrast, HPA axis activity 
dysregulation is a symptom of obstructive sleep apnea (Buckley & Schatazberg, 2005). 
Further research is focused on determining the ability of sleep disruption to predict 
daytime behavior and physiological correlates. In one study of 205 adults living in 
community housing for people with intellectual disabilities, sleep disruption was 
correlated with increased anger and challenging daytime behaviors (Brylewski & Wiggs 
2001).  
 The majority of SIB rodent research focuses on creating and refining robust 
models of SIB and potential treatment alternatives. Little emphasis has been placed on 
directly connecting the effects of nighttime activity or sleep disruption to the rodent SIB 
phenotype. One study attempted to connect sleep deprivation and the SIB correlates of 
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increased anxiety or environmental stimulation. The study demonstrated that rats with 
moderate d-amphetamine-induced SIB showed altered dopaminergic receptors leading to 
increased self-mutilating behaviors after experiencing 48hrs of REM sleep deprivation 
(Lara-Lemus et al. 1997). Outside the realm of SIB, sleep deprivation has shown both 
psychotropic and physiological effects suggesting an additional role in SIB subjects. A 
study of rodents treated with clomipramine, a treatment known to induce clinical 
depression in rodents, demonstrated increased REM sleep fragmentation and longer 
periods of nonREM (Savelyev et al. 2012). These studies show that even in rodent 
models sleep and depression may be closely related to SIB as sleep deprivation increases 
a subject’s vulnerability to stress. This concept is supported in an additional study 
exploring the effects of sleep deprivation on rat neuroendocrine function showing that 
sleep deprivation increased stress reactivity and predisposed subjects to a hypersensitivity 
to stress (Meerlo et al. 2008). While there is lacking rodent research in this specific field, 
we can make a strong case for a relationship between sleep disruption and SIB based on 
the overlaps in human, macaque, and nonSIB rodent sleep literature. 
 
1.3 Chronic HPA Axis Dysregulation 
One important factor that appears to be related to SIB is dysregulation of the 
hypothalamic-pituitary-adrenal axis (HPA). This axis is one arm of the stress response 
system. Cortisol is an important biomarker for stress and has several downstream affects 
such as preparing the body for the “fight or flight” response via glucose break down 
(Kyrou et al. 2008). More importantly, a negative feedback loop is initiated post-cortisol 
release inhibiting further HPA activity (Kyrou et al. 2008). Complications can arise when 
this negative feedback system fails to initiate properly, and excess cortisol is produced 
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(hypercortisolemia) (Nieman et al. 2008) or when repeated exposure to chronic stressors 
leads to reduced stress response (Kyrou et al. 2008).  
Cortisol can be measured in several ways including: fecal and urine samples, in 
saliva, and in blood samples. These methods are problematic because they are point 
samples and influenced by the natural circadian rhythm of cortisol. In the early morning 
cortisol levels naturally reach peak concentrations and decrease over time (Meyer & 
Novak 2012). However, these sampling matrices do not provide an estimate of chronic 
stress exposure. More recently, a chronic assessment has been developed by measuring 
cortisol in hair (Davenport et al. 2006). This sampling matrix provides an integrated 
measure of cortisol concentrations over 3 months in macaques.  
Dysregulation of the HPA axis has been consistently observed both in plasma and 
hair samples in monkeys. Monkeys with SIB show chronically lower levels of plasma 
cortisol in response to the stress of sedation and venipuncture (Tiefenbacher et al. 2000, 
2004) and chronically elevated levels of hair cortisol. It is also interesting to note that one 
of the major hormones in the HPA axis is corticotrophin-releasing hormone (CRH) which 
has been reportedly implicated in episodes of insomnia (Kyrou et al. 2008) further 
strengthening the argument for a relationship between sleep disruption in NHPs and HPA 
axis activity. Chronic elevations of the HPA axis, as determined by measuring cortisol in 
hair, have been observed in monkeys with SIB (Davenport et al. 2008). 
However, the literature surrounding HPA axis activity in humans with NSSI is 
lacking. One recent human study of 26 NSSI and 26 healthy control subjects reported 
higher salivary cortisol levels 30 minutes post-awakening in subjects with NSSI as 
compared to controls, but did not observe change in hair cortisol levels (Reichl et al. 
2016). A previous study of 14 females with NSSI and 14 controls, from many of the same 
 9 
authors, found hyporesponsive HPA axis activity suggesting salivary cortisol levels were 
reduced in human with NSSI (Kaess et al. 2012). Both studies report altered HPA axis 
activity, but the nature of the change is unclear. The etiologies of both human and 
nonhuman SIB are varied and represent an important area for further research. Hair 
cortisol values will shed light on pre and post probiotic treatment and give valuable 
context to deciphering sleep related effects. 
 HPA axis activity appears to be slightly more researched in rodent models of 
depression and environmental stressors, and less so in rodent SIB research. Examples of 
this relationship can be seen in early maternal separation models involving CD1 mouse 
strains. These mice demonstrated stunted development of HPA axis which in turn 
resulted in a blunted ACTH response leading to weakened ability to adapt to stressors 
(Schmidt et al. 2002). Further research in clomipramine treated rat pups has suggested 
that the hippocampus is able to communicate directly with the hypothalamus via brain 
derived neurotrophic factor (BDNF). This ability to modulate CNS stress pathways 
provides yet another connecting point potentially explaining the correlation between HPA 
axis dysregulation and SIB behavior (Savelyev et al. 2012). The literature still remains 
divided on the exact relationship of HPA axis activity and rodent SIB. In contrast a study 
in 2012 using pemoline induced rat SIB models suggested that exposure to high 
environmental stress (floor shock) had little significant influence on SIB (Bloom et al. 
2012). These result can be explained in a number of ways such as the degree of SIB 
severity and the nature of the shock stimulus, but still point toward a spectrum of SIB 
pathologies. An additional study involving pemoline induced rats and pretesting anxiety 
scores on the elevated plus maze test, in agreeance with the Bloom study, explains that 
pre-anxiety screening does not significantly correlate with susceptibility to SIB. The 
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paper does however show the use of anxiogenic drugs with induced SIB seemingly 
exaggerates the pathology (Yuan & Devine 2016). This paper elucidates the difficulty in 
deciphering an exact cause and effect relationship in the SIB pathology. The contending 
literature leaves much room for further research and warrants more comparison between 
induced rodent SIB with spontaneously occurring SIB or NSSI.  
 
1.4 Psychoactive Treatment 
An effective treatment for SIB must demonstrate influence over at least two of 
three correlates; sleep disruption, cortisol concentrations, and anxious behaviors. SIB 
itself has been reduced through pharmacotherapy but none of these studies examined 
sleep disruption, cortisol concentrations, or anxious behaviors. Various drugs have shown 
some efficacy in reducing SIB including naltrexone (an opiate antagonist (Kempf et al. 
2012), fluoxetine (a selective serotonin reuptake inhibitor SSRI) (Fontenot et al. 2009), 
and guanfacine (an alpha 2 adrenergic receptor agonist) (Freeman et al. 2015). 
Administration of an anxiolytic drug in the form of benzodiazepine (Tiefenbacher et al. 
2005) was effective in some animals but others were made worse.  
Whether efficacy persists after drug removal remains largely unknown. 
Additionally, it is unclear if further treatment is necessary or if drug dependency would 
require continued administration to maintain improved SIB conditions. This continued 
treatment represents a large financial burden and disqualifies many research animals from 
further study.  
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1.5 Probiotic Treatment as an Alternative 
Probiotics are organisms that exists in a mutualistic manner within the gut 
microbiome in animals and convey some benefit to their host. Having first been 
discovered in the 1900s they have since become an important and promising treatment 
alternative in both humans and animals. Probiotics may prove to be a long-term treatment 
with the ability to colonize the gut microbiome in just 2 weeks with little to no severe or 
psychotropic side-effects as reported for pharmacotherapy. The microbial density will, 
however, decrease in the following weeks following removal of probiotic 
supplementation suggesting the need for continued administration (Bouhnik et al. 1992). 
Probiotics can be ingested orally as both live and heat-treated strains, transferred between 
healthy and unhealthy humans via an uncommon procedure termed fecal microbiota 
transplant (FMT) (Van Nood et al. 2013), and are also found naturally within healthy 
human and animal microbiomes (Morita et al. 2008).  
One genus of gram negative bacteria, Lactobacillus, has been closely studied in 
recent years. Included in this genus is one of the more common strains, Lactobacillus 
reuteri (L. reuteri), naturally found in the gut flora of mammals and birds (Sarra et al. 
1985, Naito et al. 1995). Commonly it can be isolated from meat and milk products and 
more importantly it can be passed maternally to offspring via breast milk (Sinkewicz & 
Nordstrom 2005). An important distinction is that L. reuteri is found in the gut of animals 
in species specific strains (Naito et al. 1995). 
Outside the realm of sleep, Lactobacillus has already begun to show promise as a 
treatment for some disease and immunological threats. For example, daily dietary 
supplementation of L. reuteri has been shown to confer resistance to potent gram-
negative bacteria such as Helicobacter pylori (Imase et al. 2007, Francavilla et al. 2008), 
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Salmonella typhimurium (Casas & Dobrogosz 2000), and Escherichia coli (Edens et al. 
1997). Further research has determined a potential mechanism in which L. reuteri 
releases a broad-spectrum antibiotic, reuterin that inhibits the growth and development of 
certain gram-positive and negative bacteria in the gut (Talarico et al. 1988). Lactobacillus 
strains have seen increased usage in irritable bowel syndrome (IBS) clinical trials 
(Szajewska et al. 2005) and in adolescent abdominal pain research. L. reuteri has even 
been demonstrated to improve oral health by out-competing bacterial Streptococcus 
strains thought to attack enamel (Nikawa et al. 2004) and reducing incidences of 
gingivitis (Krase et al. 2006).  
Behavioral stress related impacts of Lactobacillus strains have been recently 
shown in rodent models. One strain, Lactobacillus rhamnosus, was demonstrated to 
modulate emotional behavior (Bravo et al. 2011) and in a separate mouse study, 
administration of L. reuteri showed reduced stress and anxiety (Marin et al. 2017). 
Another recent study involving Lactobacillus helveticus saw beneficial effects on 
emotional learning in rats exposed to early-life stress (Cowan et al. 2016).  
Most human clinical trials exploring probiotic treatments revolve around 
gastrointestinal disorders, but some studies have begun to look at behavioral and anxiety 
reducing benefits of certain strains. Aptly named “Psychobiotics” these specific strains of 
probiotics work through the novel pathway known as the brain-gut axis (Dinan et al. 
2013). These probiotics include a range of strains including Lactobacillus, Escherichia, 
Candida, Streptococcus, and Bifidobacterium to name a few (Dinan et al. 2013). 
Examples can be found in the emerging literature as administration of Lactobacillus 
helveticus taken in combination with Bifidobacterium longum resulted in anxiolytic 
effects in a study of humans and rodents (Messaoudi et al. 2011). A separate study 
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observed reduced anxiety after thrice daily administration of Lactobacillus casei to 
human patients suffering from chronic fatigue syndrome (Rao et al. 2009). A second 
study of young adults preparing for national medical exams demonstrated a reduction in 
salivary cortisol levels and response to stress during administration of Lactobacillus casei 
(Takada et al. 2017). These aforementioned studies already begin to highlight the efficacy 
for Lactobacillus probiotics as a potential treatment for stress, mood, and anxious 
behaviors in humans. 
 In addition to its many potential uses in combating pathogens, L. reuteri is already 
being used in a commercial context. Currently it is used in avian livestock operations as a 
growth supplement to encourage body weight increases and reduce response to stress of 
overcrowding (Casas et al. 1998). It has also seen some use as a treatment for children 
suffering from colonic and intestinal complications (Urbanska et al. 2016, Shronikova et 
al. 1997). It is currently marketed for human consumption as an immune-strengthening, 
stress reducing, and gut health bolstering daily supplement. 
One area lacking in literature is the relationship of L. reuteri and sleep. While L. 
reuteri effects on sleep have not been directly studied, other Lactobacillus strains such as 
Lactobacillus brevis (Miyazaki et al. 2014), Lactobacillus casei (Takada et al. 2017), and 
Lactobacillus plantarum (Dhaliwal et al. 2017) have shown promise in improving sleep 
quality and efficacy. Despite growing evidence of the ability for Lactobacillus probiotics 
to regulate sleep via the brain-gut axis pathway, clear consensus has not been reached. It 
is, however, conceivable that different strains within the genus may have overlapping 
functions providing further motivation for use of the L. reuteri strain. 
The decision to use Lactobacillus reuteri was made with the knowledge that 12 of 
our 14 subjects were surrogate peer-reared (SPR), meaning they received an alternative 
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milk formula in absence of breast milk which arguably may be the primary source of L. 
reuteri in macaques. The remaining 2 subjects were maternal peer-reared (MPR) by 
mothers that were surrogate peer-reared. Therefore we can, with reasonable confidence, 
claim that our 14 subjects are likely to be deficient in L. reuteri. Indeed, recent findings 
demonstrate the presence of L. reuteri in the gut of maternally reared rhesus monkey but 
not in the gut of nursery reared monkeys (Dettmer, 2018) This lack of previous exposure 
coupled with important aforementioned research on probiotic effects, and the important 
factor that our subjects both tolerate and ingest the L. reuteri probiotic make it an ideal 
treatment candidate for this study. 
 
1.6 Objectives of this study.  
The goal of this study was to evaluate the efficacy of L reuteri administration on 
biting behavior, sleep disruption, and HPA axis activity in rhesus macaques. Our 
hypothesis was that monkeys with SIB showed heightened reactions to stressors. Because 
lactobacillus probiotics appear to reduce stress reactivity, we predicted that 
administration of L reuteri would decrease sleep disruption, sleep onset time, and 
nighttime activity. In addition we predicted a decrease in hair cortisol levels and mild 
self-biting during administration.  
It is important to remember that while we hypothesize that probiotic treatment can 
reduce the factors related to stress, it might not represent a complete cure. Sleep 
disruption is a symptom of SIB, and therefore it is more accurate to suggest we are 
treating the symptoms that may worsen SIB. The results of this study could lead to more 
clinical trials of probiotic treatment in both human and animal models. By testing 
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multiple strains of probiotic we can begin to unravel specific strain effects and potentially 
create individualized probiotic treatments. 
The study involved an ABA design in which subjects received 3 months of 
placebo (pretest), followed by three months of L. reuteri (test), and followed by 3 months 
of placebo (posttest). Thus, each subject served as its own control. The phases were 
separated by a 2 week window to control for probiotic washout. Within subject designs 
are preferred when environmental conditions are highly stable because they minimize 
between subject variability.  
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CHAPTER 2  
METHODOLOGY 
2.1 Subjects 
This probiotic nighttime behavior study was conducted on 14 rhesus macaque 
monkeys (9 males) housed at the University of Massachusetts Amherst. The monkeys 
ranged in age from 13-25 years with an average age of 17 years. Eight monkeys (3 
females and 5 males) had a mild biting pathology (SIB) which did not require medical or 
veterinary intervention with the remaining 6 subjects (2 females and 4 males) serving as 
controls. SIB status was determined from twice daily 5-minute behavioral samples 
collected both in the AM and the PM. For our experiment, 12 monkeys had been nursery 
reared at the NIH prior to transfer to UMass and 2 were born at UMass and reared by 
their nursery reared mothers in social groups. 
Eight of the subjects (SIB = 3) were housed in pens with dimensions of roughly 
4x6x8 ft. while the remaining six (SIB =5) were housed in Allentown cages with standard 
dimensions 5x6x2 ft. Pen housed subjects were maintained on bedding of wood shavings 
rotated weekly, while Allentown subjects could forage through wood shavings between 
the cross section of the metal flooring. All housing environments were spot cleaned daily 
and sanitized biweekly. All subjects were housed and cared for in accordance with the 
Animal Welfare Act and the NIH Guide to the Care and Use of Laboratory Animals. The 
subjects and their backgrounds are listed below in Table 1. 
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Table 1: Subject Information *SPR (Surrogate Peer Reared) MPR (Mother Peer Reared) 
 
Twice daily, the primates were fed monkey chow (Lab Diet) which was 
supplemented with fruit or vegetable snacks in the morning. A vigorous program of 
enrichment included spacious cage housing, exceeding the standards set by the Animal 
Welfare Act that included multiple perches and portable or stationary manipulable 
objects. Additionally, the primates received daily enrichment consisting of TV, forage 
stimulation, and edible puzzles on a weekly rotating schedule. The subjects were 
carefully maintained on 13hr/11hr light dark cycle with light onset at 7 am. Four 
monkeys were pair housed and, for this study, each pairing was treated as one subject as 
the nighttime behavior could not be accurately assigned to specific individuals. One pair 
consisted of two SIB subjects whereas the other pair consisted of two control subjects. 
Three additional pairs were housed in grooming contact only. The remaining subjects 
Subject DOB Age Sex SIB 
Maternal 
Model* 
Pen Type 
V27 05.05.99 19 M No SPR Pen 
V38 05.29.99 19 F No  SPR Pen 
V43 06.16.99 19 M Yes SPR Pen 
V42 06.14.99 19 F No  SPR Pen 
ZA65 & ZA56 05.14.02 16 F Yes  SPR Allentown  
ZA54 05.11.02 16 M No  SPR Pen 
I18 04.23.93 25 M No  SPR Allentown  
N01 04.18.03 15 M Yes  MPR Allentown  
ZA31 & ZA01 03.27.02 16 M No  SPR Pen 
ZA02 01.29.02 16 M Yes  SPR Allentown 
ZA63 05.22.02 16 M Yes  SPR Pen 
N02 02.18.05 13 F Yes  MPR Allentown  
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were housed individually or in grooming contact. Extensive attempts to pair house these 
subjects had resulted in severe aggression.  
 
2.2 Probiotic Administration 
During the pretest and posttest phases the monkeys received a small chewable 
orange flavored tablet placebo from Bioserv. During the probiotic phase subject received 
a mandarin orange flavored chewable table with two strains of L. reuteri (L. reuteri 
ATCC PTA 6475 & L. reuteri DSM 17938) containing on average 200 million colony 
forming units per chewable tablet. The probiotic is commercially available as Gastrus by 
the company BioGaia. The author was blind to probiotic phase start throughout the study. 
 
2.3 Equipment 
This current study utilized the following equipment: two Dell Inspiron 3000 
laptops connected to three 1.0 Megapixel USB Cameras (Power DC5V) with built in IR 
light. The infrared cameras were connected via USB to the iSPYCONNECT 64-bit 
motion detection recording software for windows. The built in IR light allowed the 
cameras to seamlessly shift between light and dark cycles within colony rooms. 
ISPYCONNECT 64-bit software is an open source tool most commonly used in home 
security and motion detection. The software relies on direct USB connection to the 
cameras and pre-programmed recording requirements making it an ideal software for this 
study.  
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2.4 Procedure 
Nighttime video surveillance was conducted on all subjects during designated 
weeks with 3-4 monkeys scored per night for 4 nights per week, resulting in all subjects 
scored in a given week. The subjects were randomized across rooms using “The Hat” 
application for Windows operating system. The 12 subject IDs were listed and then 
randomized for 10 seconds before ordering the results. The subjects were randomized 
such that no subject could be recorded on the same day of the week during sequential 
weeks for more than two weeks. For example, if after three randomization intervals V27 
was selected for Monday video collection three weeks in a row the entire group was 
again randomized for another 10 seconds.  
 For this study, a recording schedule was established to begin at 6:00PM and to 
end at 7:00AM the next day. Each camera was set up prior to 6:00PM and oriented so 
that it faced across from the subject’s cage with substantial room to include the entire 
cage frame within the camera lens (Screenshot 1). Laptops were positioned outside of the 
room and connected to cameras via a long USB cord under the colony room door. The 
laptops were on throughout the night and their placement outside of the room reduced 
light disruption during recording.  
 
 
Screenshot 1: Example of nighttime recording with (left) subject V27 laying in lateral recumbency on 
perch and (right) subject V43 laying prone in hammock. 
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Movement detection zones allowed the experimenter to focus the camera onto the 
subject and eliminate interference from the surrounding environment (Screenshot 2). Pre-
programmed recording time allowed the experimenter to set up the cameras prior to the 
recording period further reducing disruption prior to lights off. The iSPY program was 
configured to record at the highest sensitivity of 0.001 pixel changes and set to stop 
recording 5 seconds after the movement ceased. Threshold values correspond to the total 
amount of pixel change detected across an image. 0.001 is the lowest threshold setting 
available and corresponds to percentage of total pixel color change. Recording was 
initiated if 0.1% of total pixels in the detection zone changed gray scale color. 
 
 
Screenshot 2: Example Detection zone (left side) on subject ZA63. Movement is only detected within the 
light gray box, therefore subject ZA54’s (right) movements will not be detected. 
 
2.5 Nighttime Activity Measures 
Nighttime activity data were extracted the following day by manually merging all 
video clips taken the previous night and using the file explorer program to obtain our 
measures of interest (see Table 2 below for measures and their definitions). The iSPY 
program records and saves the generated videos for each camera automatically and 
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separately files them. The experimenter reviewed camera footage recorded during the 
time frame, rated video quality, and merged the files for later analysis. Videos were 
visually evaluated to ensure that movement was properly recorded, recording was not 
interrupted, and subjects were clearly visible during the night. If the recording was 
insufficient or disrupted in any way the trial was considered a mistrial and replaced by an 
additional recording.  
The measures below (Table 2) were recorded and converted into seconds 
rounding up to the nearest hundredths place. The files were manually sorted so that only 
data collected between 8:00PM and 7:00AM were processed. By highlighting multiple 
clips, the experimenter could determine the total amount of time in seconds across the 
TMT, TMT1HR, and TMT11HR intervals (Screenshot 3). To calculate the VideoSum, 
Num10s, Num30s, and LV measures, the experimenter highlighted all the videos and 
sorted by video length. Once the files were ordered by magnitude they could be easily 
sorted for the aforementioned categories by highlighting the files of interest. 
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Table 2: Nighttime Activity Measures and Their Definitions 
Measure Abbreviation Description 
Total Movement 
Time 
TMT The sum of all movements recorded from 8:00PM – 
7:00AM. 
Total Movement 
Time in First 
Hour 
TMT1HR Total movement time recorded in first hour of lights 
off from 8:00PM – 9:00PM. 
Total Movement 
Time in Last 
Hour 
TMT11HR Total movement time recorded in last hour from 
6:00AM – 7:00AM. 
Longest Video LV The longest single video recorded in each trial. 
Number of 
Videos Per 
Session 
VideoSum The total number of video clips generated during 11 
hours of recording. 
Number of 
Greater than 
10second videos 
Num10s The sum of all motion detection clips longer than 10s 
during recording from 8:00PM – 7:00AM. 
Number of 
Greater than 
30second videos 
Num30s The sum of all motion detection clips longer than 30s 
during recording from 8:00PM – 7:00AM. 
Total Movement 
Time 2 Hours 
Prior to Lights 
off 
TMTDAY Total movement time recorded in the two hours before 
lights off from 6:00PM-8:00PM. 
 
 
 
Screenshot 3: Manual scoring of TMT between 8:00PM – 7:00AM. Note that not all videos generated are 
shown, but they are all selected and the TMT can be seen in the right-hand details column. 
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2.6 Exclusion Criteria for the Nighttime Trials 
 Videos were considered mistrials if: the session was interrupted or stopped 
recording, cameras had shifted angle, or a subject in another cage came into frame. Often 
times an automatic PC update could result in a failed trial or unknowingly alter the 
presets. The total number of videos scored and videos that were excluded can be found in 
table 3 below. We had an overall rate of 16% of trials were excluded due to exclusion 
criterion or software malfunctions.  
 
Table 3: Total Number of Videos Excluded From Final Analysis Based on Criterion 
Subject Total Videos Scored Videos Mistrials 
V27 33.00 28.00 5.00 
V38 32.00 29.00 3.00 
V43 30.00 27.00 3.00 
V42 27.00 26.00 1.00 
ZA65 & ZA56 30.00 28.00 2.00 
ZA54 32.00 27.00 5.00 
I18 34.00 27.00 7.00 
N01 32.00 27.00 5.00 
ZA31 & ZA01 32.00 28.00 4.00 
ZA02 38.00 25.00 13.00 
ZA63 36.00 26.00 10.00 
N02 33.00 29.00 4.00 
Total 389.00 327.00 62.00 
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2.7 Videos Per Phase 
 Table 4 below describes the number of videos per subject per phase after 
exclusion criteria was applied.  
 
Table 4: Total Number of Videos Per Subject Per Phase 
Subject Subject PRE 
Subject 
TEST 
Subject 
POST TOTAL 
V27 8.00 11.00 9.00 28.00 
V38 11.00 9.00 9.00 29.00 
V43 8.00 10.00 9.00 27.00 
V42 9.00 8.00 9.00 26.00 
V28 9.00 10.00 9.00 28.00 
ZA54 7.00 11.00 9.00 27.00 
I18 8.00 10.00 9.00 27.00 
N01 7.00 11.00 9.00 27.00 
ZA31 & ZA01 8.00 11.00 9.00 28.00 
ZA02 8.00 8.00 9.00 25.00 
ZA63 7.00 10.00 9.00 26.00 
N02 10.00 10.00 9.00 29.00 
 
2.8 Estimates of Self-Biting Behavior 
 Modified frequency behavior was collected twice daily in 1-hour intervals at 
9:00-10:00 AM and 4:00-5:00 PM. Observers would position themselves in colony rooms 
opposite the subject of interest and record behavior in 15 second intervals for a total of 5 
minutes (20 intervals). Subject order was randomized every day, and the observers had to 
meet a 90% reliability criterion before being allowed to take behavioral data. Self-biting 
rates were derived from this measuring system.  
 
2.9 Evening Activity Measures  
Evening total movement time was considered in the final analysis. Evening total 
movement was scored during 6:00PM to 8:00PM period prior to lights off. 6:00PM is the 
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chosen start time to avoid any human interference as standard husbandry and research 
practices end around 5:00PM daily. It is a unique period of uninterrupted activity with 
lights on. 
 
2.10 Daytime Proxy Measures 
 In order to explore daytime behavior when video surveillance was not feasible 
due to husbandry and research projects, we created a daytime proxy measure for our 
modified frequency 5-min samples. The proxy measure was created by analyzing AM 
and PM modified frequency data during each phase for each subject. The intervals of 
modified frequency where the subject was recorded in visual explore or 5 intervals of 
social contact were counted as periods of inactivity. The number of intervals of inactivity 
were then subtracted from 20 to create an activity score.  
 
2.11 Hair Cortisol Extraction 
 In addition to behavioral and activity measures, hair cortisol was used as a 
biological marker for overall stress in our subjects. Hair cortisol is extracted using a 
novel methodology pioneered in the Meyer’s lab (Meyer et al. 2014). The methodology 
follows a number of steps to extract the cortisol. First the sample was washed twice to 
remove surface cortisol contaminants using 5mL of high performance liquid 
chromatography (HPLC) grade isopropyl alcohol on a 3min inversion cycle using a 
rotator. After two cycles of washing, the isopropyl was removed and the sample dried for 
2-3 days. The sample was then ground to a fine powder using a bead beater. In the next 
step, methanol was added and the sample incubated at room temperature for 18-24hrs on 
constant inversion. The sample was then centrifuged at 10,000 rpm for 5 minutes. And 
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the supernatant extracted and placed in a separate and sterile microcentrifuge tube for 
methanol evaporation in a vacuum evaporator. The hair cortisol was then reconstituted in 
an enzyme immunosorbent assay (EIA) diluent, which was then assayed using a standard 
commercial EIA kit. All samples for this study were run in Dr. Meyer’s lab. 
 
2.12 Data Analysis 
 The data were analyzed using Analysis of variances (ANOVA) with SIB status as 
the between subject variable and phases as the repeated measure. The analysis 
specifically looked at: TMT, ≥Num10s, ≥Num30s, TMT1HR, TMT11HR, TMTDAY, 
ProxyTMT, and LV. Findings were also confirmed with the Wilcoxon signed-rank non-
parametric test. PRISM graphing software was used to create the graphs below. The 
results of the ANOVA were further analyzed using post hoc comparisons of the phase 
means with a Bonferroni correction for multiple comparisons. There are three 
comparisons. 1) Pre vs Test, 2) Test vs Post, and 3) Pre vs. Post. 
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CHAPTER 3  
RESULTS 
3.1 Self-Biting Behavior  
Administration of L reuteri modestly decreased biting behavior in monkeys with 
SIB (see Figure 1 for the group means; F(2,12) = 5.64, p= 0.02). A comparison of 
individual subjects revealed that 6 out of 8 SIB monkeys showed a decrease in biting 
behavior. The remaining 2 subjects showed little change.  
 
Figure 1: Average of SIB self-biting rates (PRE), probiotic (PRO), and placebo (POST) phases. 
 
3.2 Nighttime Activity  
Administration of L reuteri decreased nighttime activity in all monkeys 
irrespective of SIB status as revealed by significant effects of phase. However, despite 
the decrease in nighttime activity (most notably in SIB monkeys), monkeys with SIB 
continued to show higher levels of nighttime activity compared to nonSIB monkeys. 
Specific findings are described below and a table of summary statistics is located at the 
end of this section.  
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3.3 Total Movement Time  
There was a phase effect as TMT was significantly reduced by probiotics in both 
groups (See Figure 2; F(2,20)=6.03 p=0.01). SIB subjects had significantly increased total 
movement time compared to controls and irrespective of phase (See Figure 3; 
F(1,10)=10.46 p=0.01). There was no significant effect of SIB by phase interaction 
F(2,20)=0.20 p=0.82).  
 
Figure 2: Average combined SIB and control 
nighttime total movement time across placebo 
(PRE), probiotic (PRO), and placebo (POST) 
phases 
Figure 3: Average of SIB compared to control 
nighttime total movement time across placebo 
(PRE), probiotic (PRO), and placebo (POST) 
phases. 
 
3.4 Total Movement in the First Hour 
Similarly, movement time in the first hour was reduced by probiotic treatment in 
both groups (See Figure 4; F(2,20)=6.17 p=0.01). However, SIB monkeys continued to 
show more activity in the first hour after light offset compared to nonSIB monkeys (See 
Figure 5; F(1,10)=12.04 p=0.01). There was no significant SIB by phase interaction 
F(2,20)=1.79 p=0.19). 
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Figure 4: Average combined SIB and control 
SIB nighttime total movement time in the first 
hour across placebo (PRE), probiotic (PRO), and 
placebo (POST) phases 
Figure 5: Average of SIB compared to control 
nighttime total movement time in the first hour 
across placebo (PRE), probiotic (PRO), and 
placebo (POST) phases. 
 
 
3.5 Total Movement in the Last Hour  
There was an overall phase effect demonstrating reduced activity after probiotic 
administration in both groups (See Figure 6; F(2,20)=4.29 p=0.03). There was a marginal 
main effect of SIB showing that SIB monkeys continued to show more activity during the 
hour before light onset. (See Figure 7; F(1,10)=4.52 p=0.06). There was no significant 
effect of SIB by phase interaction F(2,20)=1.88 p=0.18).  
 
Figure 6: Average combined SIB and control 
nighttime total movement time in the last hour 
across placebo (PRE), probiotic (PRO), and 
placebo (POST) phases 
Figure 7: Average of SIB compared to control 
nighttime total movement time in the last hour 
across placebo (PRE), probiotic (PRO), and 
placebo (POST) phases.
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3.6 Longest Video  
Once again, L reuteri treatment reduced the length of the longest video time in 
both groups. (See Figure 8; F(2,20)=7.00 p=0.01. There was also a SIB effect as the SIB 
group generated on average significantly longer videos (See Figure 9; F(1,10)=5.54 
p=0.04) There was no significant effect of SIB by phase interaction F(2,20)=1.09 p=0.35).  
 
Figure 8: Average combined SIB and control 
longest nighttime video generated across placebo 
(PRE), probiotic (PRO), and placebo (POST) 
phases. 
Figure 9: Average of SIB compared to control 
longest nighttime video generated across placebo 
(PRE), probiotic (PRO), and placebo (POST) 
phases.
 
3.7 Total Number of Videos Generated 
Probiotic treatment was associated with a reduction of total videos generated 
across phase. (See Figure 10; F(2,20)=4.42 p=0.03). There was also a SIB effect as the SIB 
group continued to generate on average significantly more videos (See Figure 11; 
F(1,10)=5.89 p=0.04.) There was no significant effect of SIB by phase interaction 
F(2,20)=0.35 p=0.71). 
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Figure 10: Average combined SIB and control 
total nighttime videos generated across placebo 
(PRE), probiotic (PRO), and placebo (POST) 
phases.  
Figure 11: Average of SIB compared to control 
total nighttime videos generated across placebo 
(PRE), probiotic (PRO), and placebo (POST) 
phases. 
 
3.8 Total number of Videos Generated ≥10s 
As in all previous measures, there was a phase effect demonstrating reduction of 
≥10second videos generated in both groups. (See Figure 12; F(2,20)=3.39 p=0.05. There 
was also a SIB effect as the SIB group continued to generate on average significantly 
more ≥10s videos (See Figure 13; F(1,10)=6.59 p=0.03.) There was no significant effect of 
SIB by phase interaction F(2,20)=0.93 p=0.41). 
 
Figure 12: Average combined SIB and control 
≥10s nighttime videos across placebo (PRE), 
probiotic (PRO), and placebo (POST) phases. 
      
Figure 13: Average of SIB compared to control 
≥10s nighttime videos across placebo (PRE), 
probiotic (PRO), and placebo (POST) phases
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3.9 Total number of Videos Generated ≥30s  
There was no overall phase effect as the number of ≥30second videos generated 
in both groups remained the same across treatment conditions. (See Figure 14; 
F(2,20)=1.88 p=0.18). There was however a significant SIB effect as the SIB group 
generated on average significantly more ≥30s videos (See Figure 15; F(1,10)=5.05 p=0.05). 
There was no significant effect of SIB by phase interaction F(2,20)=1.85 p=0.18). 
 
Figure 14: Average combined SIB and control 
≥30s nighttime videos across placebo (PRE), 
probiotic (PRO), and placebo (POST) phases. 
      
Figure 15: Average of SIB compared to control 
≥30s nighttime videos across placebo (PRE), 
probiotic (PRO), and placebo (POST) phase.
 
Table 5: Table of Significant Nighttime Measures 
Behavior 
 
SIB Effect Phase Effect SIB x Phase 
Interaction 
Pre vs. 
Test 
Test vs. 
Post 
Pre vs. 
Post 
TIME 
VALUES 
      
TMT 10.46, p=0.01 6.03, p=0.01 0.20, p=0.82 p=0.08 p=0.93 p=0.02 
TMTHR1 12.04, p=0.01 6.17, p=0.01 1.79, p=0.19 p=0.01 p=1.00 p=0.08 
TMTHR11 4.52, p=0.06 4.29, p=0.03 1.88, p=0.18 p=0.01 p=1.00 p=0.01 
Longest 
VID 
5.54, p=0.04 7.00, p<0.01 1.09, p=0.35 p<0.01 p=1.00 p<0.01 
       
FREQ. 
VALUES 
      
Total VIDS 5.89, p=0.04 4.42, p=0.03 0.35, p=0.71 p=0.16 p=0.96 p=0.06 
10>sec 
VIDS 
6.59, p=0.03 3.39, p=0.05 0.93, p=0.41 p=0.08 p=0.01 p<0.01 
30>sec 
VIDS 
5.05, p=0.05 1.88, p=0.18 1.85, p=0.18    
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3.10 Daytime and Early Evening Behavior 
Two measures of daytime activity were examined, and a summary of the 
statistical results are reported in table 6. In the first, the surveillance software was used to 
measure activity in the two hours before sleep onset. There was no overall phase effect as 
the number of seconds of early evening activity remained unchanged in both groups as a 
function of treatment condition. (See Figure 16; F(2,20)=0.33 p=0.72). However, there was 
a significant SIB effect as the SIB group showed elevated activity compared to controls 
(See Figure 17; F(1,10)=13.47 p=0.01). There was no significant SIB by phase interaction 
F(2,20)=0.07 p=0.93). 
 
Figure 16: Average of SIB compared to control total movement time 2-hours before light offset across 
placebo (PRE), probiotic (PRO), and placebo (POST) phases. 
 
To determine whether all of our nighttime effects were caused by basic 
differences in activity level, we examined our twice daily 5-minute modified frequency 
samples. We created a proxy activity measure from the AM and PM modified frequency 
samples by counting intervals in which no motor activity was present. There was no 
effect of SIB, Phase, or SIB by Phase interaction. 
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Figure 17: Average of SIB compared to controls evening modified frequency scores across placebo  
(PRE), probiotic (PRO), and placebo (POST) phases. 
 
Table 6: Table of Significant Daytime Measures 
Behavior 
 
SIB Effect Phase Effect SIB x Phase Interaction 
6-8 pm    
TMT 13.47, p<0.01 0.33, p=0.72 0.07, p=0.93 
    
MF Samples    
ProxyTMT 0.28, p=0.76 0.13, p=0.88 0.14, p=0.97 
 
3.11 Hair Cortisol Concentrations 
Hair cortisol values were available only for the Pre and Probiotic Phases. 
Monkeys with SIB showed elevated hair cortisol compared to controls (F(1,12)=7.28, 
p=0.02, see Figure 18). Even though hair cortisol values appear to go down with 
probiotic treatment, there was no significant phase (F(1,12)=0.87, p=0.37) or SIB by phase 
interaction (F(1,12)=0.91, p=0.36). At an individual level, 5/8 SIB subjects show a 
reduction in hair cortisol values. Two subjects showed no change and these were the 
same subjects that showed no decrease in biting behavior. One SIB subject that showed a 
reduction in biting with treatment and an increase in hair cortisol.  
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Figure 18: Average of SIB compared to controls hair cortisol values across placebo (PRE), probiotic 
(PRO), and placebo (POST) phases. 
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CHAPTER 4  
DISCUSSION 
We predicted that administration of L reuteri would decrease self-biting behavior, 
decrease sleep disruption, and reduce HPA axis activity in SIB monkeys. As expected, 
SIB monkeys showed a reduction in biting behavior and sleep disruption with probiotic 
treatment. These findings are consistent with the results of another study in which we 
showed that treatment with Bifidobacterium infantis reduced biting behavior in this same 
group of monkeys (manuscript in preparation). However, it should be noted that neither 
of these probiotic strains eliminated biting behavior entirely.  
The decrease in nighttime behavior for SIB was only partially confirmed. 
Unexpectedly, both the SIB and nonSIB monkeys showed reduced nighttime activity 
with probiotic administration. This suggests that the effect is not selective to SIB 
monkeys and in fact benefitted both groups. This finding was unexpected because the 
nonSIB monkeys showed minor sleep disruption in the pretest phases. While nighttime 
activity appeared to decrease in SIB monkeys, it still did not normalize to the level of the 
controls, and there were no significant SIB by phase interactions. 
We subsequently analyzed the SIB monkey and nonSIB monkey data separately 
for significant effects of treatment phases. In the SIB monkeys, significant effects of 
phase were detected for 3 measures (total movement time in the first hour, total 
movement time in the last hour, and length of the longest video). Marginally significant 
effects (p = < 0.09) were detected for 2 measures (total movement time and number of 
videos ≥ 10 seconds). In examining the nonSIB group, there was only one phase effect 
(total movement time in the last hour). Thus, we can suggest that SIB monkey nighttime 
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activity was reduced by the administration of L. reuteri and that probiotic treatment had a 
greater effect in SIB subjects. 
The usual expectation in this ABA design was that elevated nighttime activity 
would be reinstated in the second A phase as compared to the probiotic treatment phase. 
However, reductions in nighttime activity continued through the second A phase. There 
are two possible explanations for this finding the first being that probiotic efficacy 
continued into the posttest and the second is due to another unidentified variable. To 
tackle the question of probiotic efficacy persisting, more posttest data need to be 
collected to see if nighttime activity increases. Depending on the results, we can 
determine whether the efficacy continues to remain or eventually returns to baseline, 
suggesting that the probiotic takes longer to subside than the 3 months we initially chose. 
The second possible explanation is that there may be an unidentified variable such 
as seasonality or an environmental change that caused continued suppression of nighttime 
activity only during the posttest. The posttest to this study occurred during late spring to 
early summer. We can rule out late spring to summer effects because we have evaluated 
and never seen changes in behavior that are unique to summer. It should also be pointed 
out that these monkeys live in an indoor environment under a constant day/night cycle. 
Another more likely explanation is individual variability. No obvious changes either in 
husbandry practices, enrichment experiences, or care staff occurred during any phase of 
this study. Thus, it seems unlikely that an unknown environmental factor was responsible 
for the continued improvement of the monkeys during the posttest period.  
SIB monkeys also showed a reduction in cortisol concentrations during treatment. 
This effect was also reported when the same group of monkeys was treated with another 
psychoactive probiotic, Bifidobacterium infantis. These findings are consistent with both 
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human and rodent studies in which treatment with these compounds either reduced HPA 
axis activity directly (Janik et al. 2015, Marin et al. 2017, Liang et al. 2015, Sudo & 
Chida et al. 2004) or when preloaded, modulated the reaction to a novel stressor (Kato-
Kataoka et al. 2016)  
The effects of psychoactive probiotics on these characteristics can be partially 
explained by an exploration of the brain-gut axis mechanisms. The brain gut axis is a 
unique pathway involving communication of the microflora to the brain through 
modulation of the immune system, neuroendocrine, and the neural pathways to exert its 
influence. However, it should be noted that many of these pathways are best explored and 
represented in rodent research and may not reflect the diversity of human and NHP 
conditions. 
One of the more notable hypotheses surrounding the mechanism of psychobiotics 
is that transcription of GABA (inhibitory neurotransmitter) and glutamate (excitatory 
neurotransmitter) are somehow upregulated in varying cortical regions and down 
regulated in others by probiotic gut flora. More specifically this was shown in clinically 
healthy rodent models given oral doses of L.rhamnosus probiotic (Janik et al. 2015). The 
hypothesized mechanism still remains unclear but can be explained through increased 
regulation of GABA and glutamate related genes, metabolic products of altered gut flora, 
or by direct synthesis of GABA via bacteria after administration of probiotics. The effects 
of increased GABA can be seen in an older study that replicated the SIB phenotype in 
rodents by giving intranigral injections of GABA agonist muscimol. In the experiment 
the rodent subjects were given direct injections of muscimol into regions of the substantia 
nigra which resulted in dose dependent SIB behavior (Baumeister & Frye 1984). These 
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studies make a strong case for GABA as a major component in the brain gut axis and 
possible explanation for probiotic effect on SIB. 
Another proposed mechanism is through the production and release of 
neuropeptides and or metabolites from microflora in the gastrointestinal tract. These 
products are able to cross the blood brain barrier to act directly on the hypothalamus and 
other important brain regions. Many of these pathways influence locations that regulate 
stress, anxiety, and depression. Examples of this can be seen in the research by Marin and 
collaborators who showed that the addition of Lactobacillus probiotic had the ability to 
outcompete other commensal microflora resulting in a decreased production of 
kynurenine and a return to homeostasis reversing the effect of previous stressors (Marin 
et al. 2017).  
Rodent research further supports the idea of a more closely related HPA axis and 
SIB pathology. One such paper has touted the ability of Lactobacillus helveticus NS8 to 
improve rodent stress in a chronic restraint depression model. The authors argue that 
administration of the probiotic lead to reduced plasma cortisol levels, anxiety, and 
depression scores on elevated maze, sucrose preference tests, open field test, object 
recognition, and object placement testing (Liang et al. 2015). The paper also tested 
biochemical markers noting increase BDNF and restored hippocampal serotonin (Liang 
et al. 2015). This study strengthens what the emerging literature has repeatedly shown, 
that the microbiome can actively alter neural pathways and have reversing effects on 
stress and depression, two proposed hypotheses that repeatedly intersect our working 
model of SIB.  
Additionally, research has looked at the post-natal period in mouse models where 
the microbiome is still developing and colonization has yet to be completed. This 
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developmental period represents a time of greater susceptibility to disease but also to 
stress. One particular experiment observed germ-free mouse strains in direct comparison 
to specific pathogen free mice and mouse models inoculated with B.infantis and showed 
that germ free mice had increased corticosterone and ACTH levels, reduced BDNF 
expression, and most notably showed that elevated HPA axis response could be partially 
resolved with fecal microbiota transplant of feces from the SPF mice treated with 
probiotic (Sudo & Chida et al. 2004). 
All of these proposed mechanisms have merit and prove that the explanation 
behind our unique findings may not be so one-dimensional. Additional research is 
warranted as determining the exact relationship may be the key to creating an effective 
treatment and eventual cure for SIB in humans and non-human primates. 
The finding of increased nighttime activity raises the question as to whether the 
differences in activity are specific to the night. When we examined the 2 hours before 
light offset, SIB monkeys were more active than nonSIB monkeys although this 
difference in activity was unaffected by treatment, remaining consistent across all phases. 
There are potential explanations for this finding. The first is that perhaps during those 
two quiet hours before sleep the subjects’ total movement time increases in anticipation 
of sleep. Alternatively, a second hypothesis is that SIB is associated with trait-like 
hyperactivity. Thus, we measured activity during our 5-modified frequency samples. It 
was not possible to use the surveillance software during the workday because of the 
numerous activities of animal care and research staff. We created the proxy measure 
outlined in the methods section. As reported in the results section the proxy measure did 
not show any activity differences between SIB and control subjects and like the evening 
measure, the daytime activity was unaffected by the treatment. Thus, it seems unlikely 
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that the SIB monkeys in this population differed from controls by being hyperactive. 
However, because the evening measure identified significant differences, it remains 
possible that the presence of observers equalized the activity, or conversely, the proxy 
measure was not an accurate assessment tool. 
Future directions might involve exploring a multi-strain probiotic or perhaps 
probiotics used in conjunction with other exogenous substances such as melatonin. The 
number of probiotics becoming commercially available are on the rise and powerful 
combinations of probiotics may hold the key to creating individualized treatment plans. 
Experimental designs that compare the efficacy of multi-strain probiotics with and 
without L.reuteri could give indication of what specific role L.reuteri plays in reduction 
of SIB and nighttime behavior. In addition to testing multi-strain probiotics, the use of 
fecal analysis to determine the exact density and growth of probiotics in subjects could 
also explain some of our findings. Pre and post fecal analysis and microbiome genotyping 
could also explain the specific mechanism used by L.reuteri as demonstrated in the 
literature. A valid future direction is to answer the question of whether certain bacteria 
are being out competed by the addition of probiotics or if an entirely different mechanism 
is at play.  
Another important consideration is whether activity is really indicative of a 
specific sleep disruption or whether it is predicated by hyperactivity across the day and 
night activity. We must then consider whether probiotics reduce both nighttime and 
daytime activity. It would also be valuable to attempt to measure subjects more than two 
times per week or to measure all animals in the same room at the same time to determine 
synchrony of behaviors. Synchrony could answer the question of whether subjects 
become habituated to the movements of the other macaques within the colony room or if 
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their behavior is affected by the other subjects. It would be useful to also combine 
techniques as suggested in the articles by Barrett 2009 and Golub & Hogrefe 2016 where 
they studied actigraphy data from implanted sensors and collars. This would be beneficial 
in creating a better sense of sleep disruption. It would be valuable to graph the time 
stamps for the 30 second videos to determine the exact spread of activity. This could 
answer the question of whether SIB subjects have more sleep disruption on one end or 
another of the night. Coupling this data with actigraphy information could clarify the type 
of activity and help further refine the novel VRNA system. Another important future 
direction is to increase the number of subjects and include different populations if 
possible. One unanswered question is whether the severity of SIB correlates with the 
severity of sleep disruption, as such it would be important to test whether L.reuteri would 
have a greater or equal effect on subjects considered intense self-biters. A follow up 
study could incorporate the use of neural imaging to look at changing neural plasticity in 
subjects undergoing probiotic treatment.  
An important next step is determining the exact relationship of SIB and sleep. 
Further exploration is needed to determine whether sleep is driven by SIB pathology or if 
SIB pathology is increased by sleep disruption. The use of sleep aids, especially 
nonpharmacological aids like melatonin or herbs like chamomile, will be invaluable in 
understanding the complex SIB phenotype. 
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